| Literature DB >> 30563338 |
Duy Nguyen1, Clara Lemos1, Lars Wortmann1, Knut Eis1, Simon J Holton1, Ulf Boemer1, Dieter Moosmayer1, Uwe Eberspaecher1, Joerg Weiske1, Christian Lechner1, Stefan Prechtl1, Detlev Suelzle1, Franziska Siegel1, Florian Prinz1, Ralf Lesche1, Barbara Nicke1, Katrin Nowak-Reppel1, Herbert Himmel1, Dominik Mumberg1, Franz von Nussbaum1, Carl F Nising1, Marcus Bauser1, Andrea Haegebarth1.
Abstract
The availability of a chemical probe to study the role of a specific domain of a protein in a concentration- and time-dependent manner is of high value. Herein, we report the identification of a highly potent and selective ERK5 inhibitor BAY-885 by high-throughput screening and subsequent structure-based optimization. ERK5 is a key integrator of cellular signal transduction, and it has been shown to play a role in various cellular processes such as proliferation, differentiation, apoptosis, and cell survival. We could demonstrate that inhibition of ERK5 kinase and transcriptional activity with a small molecule did not translate into antiproliferative activity in different relevant cell models, which is in contrast to the results obtained by RNAi technology.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30563338 DOI: 10.1021/acs.jmedchem.8b01606
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446